Why healthcare innovation needs more than startup enthusiasm

Healthcare innovation begins with an idea, which can be a medical diagnostic tool or a digital platform to address a healthcare problem. However, an idea that works in a lab or impresses at a showcase may not be ready for implementation in a hospital setting. The real challenge lies in proving that the innovation is safe, clinically useful, affordable, and can be produced, maintained, and used effectively over time.

In Ghana, students, researchers, and entrepreneurs are addressing challenges within the health system by developing locally appropriate medical devices, diagnostic tools, and digital platforms. While their creativity is commendable, the uncertainty remains whether these ideas will progress beyond the prototype stage to become solutions trusted by clinicians, adopted by healthcare institutions, and ultimately benefitting patients.

Moving beyond the prototype is where a promising idea encounters the realities of healthcare. Unlike consumer technologies that can be released with early versions and improved through user feedback, healthcare ventures have limited room for such flexibility. An error in a diagnostic or treatment decision can jeopardize patient safety.

Thus, a prototype that performs well under controlled conditions does not guarantee consistent performance in a hospital, compliance with regulatory requirements, improvement of patient care, or suitability for the specific environment it is needed in. Therefore, the innovation journey is not just from an idea to a finished product but from proving that something can work to demonstrating its safety, clinical usefulness, affordability, and feasibility for production, maintenance, and use over time.

This process requires evidence, expertise, infrastructure, and financing, which no single innovator can provide alone. A healthcare innovation ecosystem, comprising institutions, expertise, and relationships, is crucial for assessing, improving, financing, regulating, producing, purchasing, and sustaining innovations. Universities provide research, technical talent, and early-stage development, clinicians and patients ensure solutions address real healthcare needs, regulators protect the public and guide innovators through evidence and standards, industry offers manufacturing and commercial expertise, investors provide appropriate capital, and healthcare institutions create environments for testing, procurement, and adoption.

When these connections are weak, innovators struggle to navigate a fragmented system, and promising ideas stall due to the absence of a pathway. Governments play a vital role in creating this pathway by ensuring clear, rigorous, and navigable routes through regulatory standards, accessible guidance, shared testing infrastructure, responsible clinical validation, and procurement systems that allow credible local innovations to demonstrate their value.

Additionally, funding must recognize that developing and validating a healthcare product may take longer and require more resources than launching a conventional digital service. In Ghana, initiatives like the BioInnovation Centre at Academic City University and the Medical Innovation Expo demonstrate efforts to strengthen the pathway from identifying healthcare needs through product development, validation, commercialization, and adoption.

The Expo, themed "Beyond the No-Bed Syndrome: Designing Systems That Deliver Care," aims to address the processes, relationships, and infrastructure required to deliver better care in Ghana's healthcare system. The challenge is not just to generate more ideas but to build systems that allow those ideas to survive beyond the showcase and become trusted, sustainable solutions that improve lives.

The success of healthcare innovation should be measured by its safe implementation in healthcare facilities, clinician reliance, healthcare institution sustainability, and most importantly, patient benefits.